1826-11-5 | 2-Phenylthiazole

Packsize	Purity	Availability	Price	Discounted Price
250mg	97%	in stock	$18.00	$13.00
1g	97%	in stock	$21.00	$15.00
5g	97%	in stock	$68.00	$48.00
10g	97%	in stock	$92.00	$65.00
25g	97%	in stock	$208.00	$146.00

Description

• Catalog Number: AA98301
• Chemical Name: 2-Phenylthiazole
• CAS Number: 1826-11-5
• Molecular Formula: C9H7NS
• Molecular Weight: 161.22358
• MDL Number: MFCD00272327
• SMILES: c1ccc(cc1)c1nccs1

Computed Properties

• Complexity: 121
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 1
• XLogP3: 2.6

Literature

• An investigation of phenylthiazole antiflaviviral agents.

  Bioorganic & medicinal chemistry 20110615

• Bis(2-amino-1,3-benzothia-zol-3-ium) tetra-chloridozincate(II).

  Acta crystallographica. Section E, Structure reports online 20110601

• Relating patenting and peer-review publications: an extended perspective on the vascular health and risk management literature.

  Vascular health and risk management 20110101

• Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents.

  European journal of medicinal chemistry 20101101

• 1'-Acetyl-3-phenyl-6-oxa-4-thia-2-aza-spiro-[bicyclo-[3.2.0]hept-2-ene-7,3'-indolin]-2'-one.

  Acta crystallographica. Section E, Structure reports online 20100901

• Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.

  Journal of medicinal chemistry 20090326

• Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.

  Journal of medicinal chemistry 20070308

• Synthesis and biological evaluation of new thiazolyl/benzothiazolyl-amides, derivatives of 4-phenyl-piperazine.

  Farmaco (Societa chimica italiana : 1989) 20050101

• Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5.

  Bioorganic & medicinal chemistry letters 20041004

• Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements.

  The Journal of pharmacy and pharmacology 20010601